Cochlear reported $171.6M in EBIT for its first fiscal semester of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Ansell ANN:AU $ 211.56M 54.95M
Cochlear COH:AU $ 171.6M 51.4M
CSL CSL:AU $ 1.28B 2.02B
Estia Health EHE:AU $ -47859000 59.61M
Fisher Paykel Healthcare FPH:NZ 203.2M 99.2M
Healius Ltd HLS:AU $ 114.9M 258.6M
Integral Diagnostics Ltd IDX:AU 17.58M 3.04M
Japara Healthcare JHC:AU -15896000 2.75M
Mayne Pharma MYX:AU $ -35395000 17.98M
Monash IVF Group Ltd MVF:AU 11.53M 7.85M
Nanosonics Ltd NAN:AU $ -1988000 5.82M
Opthea Ltd OPT:AU -54280408.54 33.47M
Polynovo Ltd PNV:AU -1689730 3.47M
Ramsay Health Care RHC:AU $ 108.5M 201.2M
Regis Healthcare REG:AU -28986000 64M
ResMed RMD:AU $ 372.79M 138.52M
Sigma Healthcare Ltd SIG:AU 8.42M 225K
Somnomed Ltd SOM:AU -1516750 1.1M
Sonic Healthcare SHL:AU $ 948.26M 260.51M
Telix Pharmaceuticals Ltd TLX:AU -69193000 22.27M
Virtus Health VRT:AU 24.95M 3.75M